ADCendo is a startup company based on an antibody-drug-conjugate, which is capable of curing cancer in a mouse model of disease
FerroSens offers the world’s first non-invasive screening device for iron deficiency at the point-of-care.
ImmuCon develops a proprietary “first-in class” monoclonal antibody against IL-3 for treatment of patients with systemic lupus erythematosus (SLE).
aBACTER is an innovative project team focused on the development of novel antibiotics exhibiting excellent potency against WHO-priority pathogens.
Our vision is to reduce cancer mortality by predicting the most efficient cancer treatments for individual patients and to accelerate drug discovery.
Providing new injectable biomatrix to treat early stage disc degeneration as well as early osteoarthritis in the knee and hip.
Silvacx is an emerging startup developing rationally designed, nanoparticle-based immunotherapeutics against cancer and infectious diseases.